NSE · India · data to 2026-10-21
Aurobindo Pharma Ltd. (AUROPHARMA)
Aurobindo Pharma Ltd.: ₹1,621 on 2026-10-21. +19.0% a year since 2003, worst fall -87%. Year-by-year returns, risk profile and what followed its price patterns in the past.
Open the interactive chart and full historyKey numbers
| Last close | ₹1,621 |
| Return a year since 2003 | +19.0% |
| All-time high | ₹1,734 (2026-09-18) |
| Below its high | -6.5% |
| Worst fall | -87% (2008-11-06) |
| Yearly volatility | 41% |
| Beta vs its index | 0.82 |
| Risk / reward vs its market | Low risk · High reward |
Returns by year
| Year | Return |
|---|---|
| 2026 | +37.1% |
| 2025 | -11.4% |
| 2024 | +23.1% |
| 2023 | +147.3% |
| 2022 | -40.3% |
| 2021 | -20.3% |
| 2020 | +101.7% |
| 2019 | -37.7% |
| 2018 | +6.5% |
| 2017 | +2.8% |
| 2016 | -23.6% |
| 2015 | +54.3% |
What followed its price patterns in the past
How often AUROPHARMA was higher 40 trading days after each pattern, next to an ordinary day. History for learning, not a forecast.
| Pattern | Past cases | Higher after 40 days | On an ordinary day | Median move |
|---|---|---|---|---|
| Volume spike on an up day | 110 | 62% | 57% | +4.6% |
| Volume spike on a down day | 77 | 48% | 57% | -0.4% |
| New 52-week high | 76 | 71% | 57% | +8.5% |
| RSI rises above 70 | 72 | 68% | 57% | +9.2% |
| Big up day | 71 | 62% | 57% | +4.7% |
| Up streak | 71 | 61% | 57% | +4.8% |
| Down streak | 71 | 51% | 57% | +0.2% |
| Big down day | 54 | 57% | 57% | +4.5% |
| RSI drops below 30 | 47 | 62% | 57% | +4.0% |
| Squeeze breakout up | 41 | 44% | 57% | -2.4% |
| Crosses above 200-day avg | 40 | 65% | 57% | +5.5% |
| Falls below 200-day avg | 37 | 51% | 57% | +1.4% |
ZOSH shows history and calculations for learning. It is not investment advice and does not tell anyone to buy or sell. Data: Yahoo Finance, AMFI, NSE and official sources; it can be late or wrong, so check before acting.